Piramal Enterprises Limited — Important, 27-01-2025: Updates

A penalty of ₹15.44 crore has been levied against Piramal Pharma Limited for incorrect classification of goods under the Central Goods and Services Tax, 2017. This order, issued by the Additional Commissioner in Mohali, relates to a period before the demerger of Piramal Pharma from Piramal Enterprises Limited. Importantly, this issue does not impact the financials, operations, or other activities of Piramal Enterprises, as the penalty is associated specifically with the demerged entity. Overall, the situation appears manageable with no immediate implications for Piramal Enterprises investors.